Oral medicine for treating cerebral blood-supply deficiency giddiness and cava infarction and hyperthrombinemia

A technology for cerebral insufficiency and blood viscosity, applied in the field of plant materials, can solve problems such as inaccurate curative effect

Active Publication Date: 2007-01-17
HUNAN JIUDIAN PHARMA
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main drugs used for the above diseases are Qiangli Dingxuan Tablets, Naoluotong Capsules, etc., all of which are the original local standard drugs, and the curative effect is not accurate enough.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral medicine for treating cerebral blood-supply deficiency giddiness and cava infarction and hyperthrombinemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Taking the production of 1000 capsule products of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0038] Gastrodia elata 300g Pueraria 600g

[0039] Chuanxiong 300g Poria cocos 600g

[0040] Angelica 300g Stir-fried Atractylodes macrocephala 240g

[0041] Add starch to 400g.

[0042] Its preparation process is carried out according to the preparation process of the capsule of the present invention. Each capsule weighs 0.4g, and each capsule contains 2.34g of traditional Chinese medicine raw materials. It is taken orally 3 times a day, 3 capsules each time.

[0043] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0044]Gastrodia elata 225g Pueraria 450g

[0045] Chuanxiong 225g Poria cocos 450g

[0046] Angelica 225g Stir-fried Atractylodes Rhizoma 180g

[0047] A...

Embodiment 2

[0068] Taking the production of 1000 capsule products of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0069] Gastrodia elata 203g Pueraria 763g

[0070] Chuanxiong 255g Poria cocos 509g

[0071] Angelica 407g Stir-fried Atractylodes macrocephala 203g

[0072] Add starch to 400g.

[0073] Its preparation process is carried out according to the preparation process of the capsule of the present invention. Each capsule weighs 0.4g, and each capsule contains 2.34g of traditional Chinese medicine raw materials. It is taken orally 3 times a day, 3 capsules each time.

[0074] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0075] Tianma 153g Pueraria 572g

[0076] Chuanxiong 191g Poria cocos 381g

[0077] Angelica 305g Stir-fried Atractylodes Rhizoma 153g

[0078] Add starc...

Embodiment 3

[0099] Taking the production of 1000 capsule products of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0100] Gastrodia elata 288g Pueraria 767g

[0101] Chuanxiong 230g Poria cocos 575g

[0102] Angelica 288g Stir-fried Atractylodes macrocephala 192g

[0103]Add starch to 400g.

[0104] Its preparation process is carried out according to the preparation process of the capsule of the present invention. Each capsule weighs 0.4g, and each capsule contains 2.34g of traditional Chinese medicine raw materials. It is taken orally 3 times a day, 3 capsules each time.

[0105] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0106] Gastrodia elata 216g Pueraria 575g

[0107] Chuanxiong 173g Poria cocos 431g

[0108] Angelica 216g Stir-fried Atractylodes macrocephala 144g

[01...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An orally taken Chinese medicine for treating the dizziness caused by cerebral ischemia, high-viscosity blood, etc is prepared from 6 Chinese-medicinal materials including pueraria root, Chuan-xiong rhizome, tuckahoe, Chinese angelica root, etc.

Description

technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, and specifically relates to materials derived from plants. Background technique [0002] Cerebral insufficiency vertigo, lacunar infarction and hyperviscosity are common clinical diseases and frequently-occurring diseases in neurology. In traditional Chinese medicine, the category of "vertigo", "stroke" and other syndromes. [0003] Vertigo is a kind of disease with dizziness as the main clinical manifestation. In mild cases, it stops when the eyes are closed. In severe cases, it is like riding a boat, erratic rotation, unable to stand, or accompanied by nausea, vomiting, sweating, and even fainting. Its scope can touch many conditions of modern medicine. Among them, those caused by insufficiency of vertebrobasilar artery blood supply are the most common clinically. [0004] Vertebrobasilar artery insuffic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P9/10A61P7/00
Inventor 王静怡
Owner HUNAN JIUDIAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap